BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 36184746)

  • 21. NUP98-NSD1 fusion in association with FLT3-ITD mutation identifies a prognostically relevant subgroup of pediatric acute myeloid leukemia patients suitable for monitoring by real time quantitative PCR.
    Akiki S; Dyer SA; Grimwade D; Ivey A; Abou-Zeid N; Borrow J; Jeffries S; Caddick J; Newell H; Begum S; Tawana K; Mason J; Velangi M; Griffiths M
    Genes Chromosomes Cancer; 2013 Nov; 52(11):1053-64. PubMed ID: 23999921
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A cryptic translocation leading to NUP98-PHF23 fusion in AML.
    Ning Y
    Best Pract Res Clin Haematol; 2016 Dec; 29(4):320-323. PubMed ID: 27890253
    [TBL] [Abstract][Full Text] [Related]  

  • 23. NUP98 Fusion Proteins Interact with the NSL and MLL1 Complexes to Drive Leukemogenesis.
    Xu H; Valerio DG; Eisold ME; Sinha A; Koche RP; Hu W; Chen CW; Chu SH; Brien GL; Park CY; Hsieh JJ; Ernst P; Armstrong SA
    Cancer Cell; 2016 Dec; 30(6):863-878. PubMed ID: 27889185
    [TBL] [Abstract][Full Text] [Related]  

  • 24. NUP98-NSD3 fusion gene in radiation-associated myelodysplastic syndrome with t(8;11)(p11;p15) and expression pattern of NSD family genes.
    Taketani T; Taki T; Nakamura H; Taniwaki M; Masuda J; Hayashi Y
    Cancer Genet Cytogenet; 2009 Apr; 190(2):108-12. PubMed ID: 19380029
    [TBL] [Abstract][Full Text] [Related]  

  • 25. NUP98-NSD1 links H3K36 methylation to Hox-A gene activation and leukaemogenesis.
    Wang GG; Cai L; Pasillas MP; Kamps MP
    Nat Cell Biol; 2007 Jul; 9(7):804-12. PubMed ID: 17589499
    [TBL] [Abstract][Full Text] [Related]  

  • 26. SETD2 deficiency accelerates MDS-associated leukemogenesis via S100a9 in NHD13 mice and predicts poor prognosis in MDS.
    Chen BY; Song J; Hu CL; Chen SB; Zhang Q; Xu CH; Wu JC; Hou D; Sun M; Zhang YL; Liu N; Yu PC; Liu P; Zong LJ; Zhang JY; Dai RF; Lan F; Huang QH; Zhang SJ; Nimer SD; Chen Z; Chen SJ; Sun XJ; Wang L
    Blood; 2020 Jun; 135(25):2271-2285. PubMed ID: 32202636
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 10-day decitabine with venetoclax for newly diagnosed intensive chemotherapy ineligible, and relapsed or refractory acute myeloid leukaemia: a single-centre, phase 2 trial.
    DiNardo CD; Maiti A; Rausch CR; Pemmaraju N; Naqvi K; Daver NG; Kadia TM; Borthakur G; Ohanian M; Alvarado Y; Issa GC; Montalban-Bravo G; Short NJ; Yilmaz M; Bose P; Jabbour EJ; Takahashi K; Burger JA; Garcia-Manero G; Jain N; Kornblau SM; Thompson PA; Estrov Z; Masarova L; Sasaki K; Verstovsek S; Ferrajoli A; Weirda WG; Wang SA; Konoplev S; Chen Z; Pierce SA; Ning J; Qiao W; Ravandi F; Andreeff M; Welch JS; Kantarjian HM; Konopleva MY
    Lancet Haematol; 2020 Oct; 7(10):e724-e736. PubMed ID: 32896301
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical and Biological Characteristics of 14 Adult Cases of
    Sun YJ; Wang W; Lu SQ; Li LR
    Turk J Haematol; 2023 Dec; 40(4):281-283. PubMed ID: 37723856
    [No Abstract]   [Full Text] [Related]  

  • 29. NUP98-NSD1 gene fusion and its related gene expression signature are strongly associated with a poor prognosis in pediatric acute myeloid leukemia.
    Shiba N; Ichikawa H; Taki T; Park MJ; Jo A; Mitani S; Kobayashi T; Shimada A; Sotomatsu M; Arakawa H; Adachi S; Tawa A; Horibe K; Tsuchida M; Hanada R; Tsukimoto I; Hayashi Y
    Genes Chromosomes Cancer; 2013 Jul; 52(7):683-93. PubMed ID: 23630019
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The molecular pathogenesis of the NUP98-HOXA9 fusion protein in acute myeloid leukemia.
    Rio-Machin A; Gómez-López G; Muñoz J; Garcia-Martinez F; Maiques-Diaz A; Alvarez S; Salgado RN; Shrestha M; Torres-Ruiz R; Haferlach C; Larráyoz MJ; Calasanz MJ; Fitzgibbon J; Cigudosa JC
    Leukemia; 2017 Sep; 31(9):2000-2005. PubMed ID: 28630438
    [No Abstract]   [Full Text] [Related]  

  • 31. Mixed phenotype acute leukemia in a child associated with a NUP98-NSD1 fusion and NRAS p.Gly61Arg mutation.
    Ganapathi SS; Raikar SS; Yatsenko SA; Djokic M; Bukowinski A
    Cancer Rep (Hoboken); 2021 Aug; 4(4):e1372. PubMed ID: 33784031
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Novel NUP98-HOXC11 fusion gene resulted from a chromosomal break within exon 1 of HOXC11 in acute myeloid leukemia with t(11;12)(p15;q13).
    Taketani T; Taki T; Shibuya N; Kikuchi A; Hanada R; Hayashi Y
    Cancer Res; 2002 Aug; 62(16):4571-4. PubMed ID: 12183408
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Faggot cells in acute myeloid leukemia with t(7;11)(p15;p15) and NUP98-HOXA9 fusion.
    Yanagisawa H; Mizuta S; Kawabata H; Fujimoto S; Sakai T; Iwao-Kawanami H; Kawanami T; Yamada K; Fukushima T; Kyoda K; Masaki Y
    Ann Hematol; 2021 Aug; 100(8):2121-2123. PubMed ID: 32514625
    [No Abstract]   [Full Text] [Related]  

  • 34. Identification and genetic characterization of a
    Sorel N; Raimbault A; Brizard F; Depaire T; Pierini V; Dupraz C; Millot F; Mecucci C; Chomel JC
    Leuk Lymphoma; 2021 Dec; 62(14):3531-3535. PubMed ID: 34399652
    [No Abstract]   [Full Text] [Related]  

  • 35. Long-term remission of therapy-related acute myeloid leukemia with a new t(11;18)(q23;q21.2) translocation and KMT2A-ME2 (MLL-ME2) fusion gene.
    Szotkowski T; Jarošová M; Zimmermannová O; Meyer C; Marschalek R; Zuna J; Hubáček J; Indrák K
    Cancer Genet; 2015 Dec; 208(12):610-4. PubMed ID: 26556690
    [TBL] [Abstract][Full Text] [Related]  

  • 36. NUP98 is rearranged in 3.8% of pediatric AML forming a clinical and molecular homogenous group with a poor prognosis.
    Struski S; Lagarde S; Bories P; Puiseux C; Prade N; Cuccuini W; Pages MP; Bidet A; Gervais C; Lafage-Pochitaloff M; Roche-Lestienne C; Barin C; Penther D; Nadal N; Radford-Weiss I; Collonge-Rame MA; Gaillard B; Mugneret F; Lefebvre C; Bart-Delabesse E; Petit A; Leverger G; Broccardo C; Luquet I; Pasquet M; Delabesse E
    Leukemia; 2017 Mar; 31(3):565-572. PubMed ID: 27694926
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Leukemogenic mechanisms and targets of a NUP98/HHEX fusion in acute myeloid leukemia.
    Jankovic D; Gorello P; Liu T; Ehret S; La Starza R; Desjobert C; Baty F; Brutsche M; Jayaraman PS; Santoro A; Mecucci C; Schwaller J
    Blood; 2008 Jun; 111(12):5672-82. PubMed ID: 18388181
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment of therapy-related acute myeloid leukemia and underlying multiple myeloma with decitabine/venetoclax and daratumumab.
    Shoumariyeh K; Jung J; Rassner M; Dold SM; Riebl V; Pantic M; Herget G; Marks R; Lübbert M; Wäsch R; Engelhardt M
    Ann Hematol; 2021 Jun; 100(6):1637-1640. PubMed ID: 33712868
    [No Abstract]   [Full Text] [Related]  

  • 39. [Acute myeloid leukemia with NUP98 gene rearrangement: a report of 5 cases].
    Gao JJ; Dong F; Zhao W; Zhang ZH; Wang YF; Zhu MX; Wang J; Jing HM; Ke XY
    Zhonghua Xue Ye Xue Za Zhi; 2023 Oct; 44(10):866-867. PubMed ID: 38049343
    [No Abstract]   [Full Text] [Related]  

  • 40. [Acute myeloid leukemia with co-expression of TEL-ABL1 and NUP98-HOXA9 fusion genes: a case report and literature review].
    Wu CY; Li YL; Dong XY; Zhang L; Shang BJ; Li W; Li ZB; Zhang L; Zhu ZM
    Zhonghua Xue Ye Xue Za Zhi; 2020 Jul; 41(7):595-598. PubMed ID: 32810969
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.